Novel Antifungals and <i>Aspergillus</i> Section <i>Terrei</i> with Potpourri Susceptibility Profiles to Conventional Antifungals

Novel Antifungals and <i>Aspergillus</i> Section <i>Terrei</i> with Potpourri Susceptibility Profiles to Conventional Antifungals

The epidemiology of invasive fungal infections (IFIs) is currently changing, driven by aggressive immunosuppressive therapy, leading to an expanded spectrum of patients at risk of IFIs. Aspergillosis is a leading cause of IFIs, which usually affects immunocompromised patients. There are a limited nu...

Full description

Bibliographic Details
Main Authors: Roya Vahedi-Shahandashti, Jos Houbraken, Mike Birch, Cornelia Lass-Flörl
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Fungi
Subjects:
new antifungals
<i>Aspergillus terreus</i>
aspergillosis
antifungal susceptibility test
EUCAST
ibrexafungerp
Online Access:https://www.mdpi.com/2309-608X/9/6/649

Similar Items

Similar Items